These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32436051)

  • 1. Epidemiology, Associated Factors and Treatment Methods of Cutaneous Leishmaniasis Based on Previous Data from 2013 to 2018 in Ilam, Western Iran.
    Rezaee N; Raissi V; Rajaeipour A; Nazari M; Getso M; Taghipour A; Raiesi O; Ibrahim A
    Acta Parasitol; 2020 Sep; 65(3):760-767. PubMed ID: 32436051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological Trend of Cutaneous Leishmaniasis in an Endemic Focus Disease During 2009-2016, Central Iran.
    Moein D; Masoud D; Mahmood N; Abbas D
    Turkiye Parazitol Derg; 2019 Jun; 43(2):55-59. PubMed ID: 31204455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing epidemiology of cutaneous leishmaniasis in Isfahan, Iran.
    Karami M; Doudi M; Setorki M
    J Vector Borne Dis; 2013 Mar; 50(1):30-7. PubMed ID: 23703437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological Aspects of Cutaneous Leishmaniasis during 2009-2016 in Kashan City, Central Iran.
    Moein D; Masoud D; Saeed M; Abbas D
    Korean J Parasitol; 2018 Feb; 56(1):21-24. PubMed ID: 29529846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A newly emerged cutaneous leishmaniasis focus in central Iran.
    Nateghi Rostami M; Saghafipour A; Vesali E
    Int J Infect Dis; 2013 Dec; 17(12):e1198-206. PubMed ID: 24011629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride (Thio-Ben) along with cryotherapy: a single-blind randomized clinical trial.
    Daie Parizi MH; Karvar M; Sharifi I; Bahrampour A; Heshmat Khah A; Rahnama Z; Baziar Z; Amiri R
    Dermatol Ther; 2015; 28(3):140-6. PubMed ID: 25847678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.
    Aflatoonian MR; Sharifi I; Aflatoonian B; Bamorovat M; Heshmatkhah A; Babaei Z; Ghasemi Nejad Almani P; Mohammadi MA; Salarkia E; Aghaei Afshar A; Sharifi H; Sharifi F; Khosravi A; Khatami M; Arefinia N; Fekri A; Farajzadeh S; Khamesipour A; Mohebali M; Gouya MM; Shirzadi MR; Varma RS
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007423. PubMed ID: 31188834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey.
    Uzun S; Uslular C; Yücel A; Acar MA; Ozpoyraz M; Memişoğlu HR
    Br J Dermatol; 1999 Feb; 140(2):347-50. PubMed ID: 10233236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging cutaneous leishmaniasis in Sirte-Libya: epidemiology, recognition and management.
    Fathy FM; El-Kasah F; El-Ahwal AM
    J Egypt Soc Parasitol; 2009 Dec; 39(3):881-905. PubMed ID: 20120753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and epidemiological study of cutaneous leishmaniasis in two tertiary care hospitals of Jammu and Kashmir: An emerging disease in North India.
    Rather S; Wani M; Shah FY; Bashir S; Yaseen A; Giri FA; Sharma R; Zeerak S; Jabeen Y; Hassan I; Dogra D; Rishi R
    Int J Infect Dis; 2021 Feb; 103():138-145. PubMed ID: 33181331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly emerged focus of zoonotic cutaneous leishmaniasis in South-western Iran.
    Askari A; Sharifi I; Aflatoonian MR; Babaei Z; Ghasemi Nejad Almani P; Mohammadi MA; Alizadeh H; Hemati S; Bamorovat M
    Microb Pathog; 2018 Aug; 121():363-368. PubMed ID: 29709689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.
    Fikre H; Mohammed R; Atinafu S; van Griensven J; Diro E
    Trop Med Int Health; 2017 Oct; 22(10):1293-1301. PubMed ID: 28712122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cutaneous leishmaniasis infection and clinico-epidemiological patterns among military personnel in Mullaitivu and Kilinochchi districts of the Northern Province, early war-torn areas in Sri Lanka.
    Gunathilaka N; Semege S; Pathirana N; Manamperi N; Udayanga L; Wijesinghe H; Premaratne P; Fernando D
    Parasit Vectors; 2020 May; 13(1):263. PubMed ID: 32430014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Mapping and Situational Analysis of Cutaneous Leishmaniasis in an Endemic Area of Central Iran: A GIS-Based Survey.
    Abedi-Astaneh F; Hajjaran H; Yaghoobi-Ershadi MR; Hanafi-Bojd AA; Mohebali M; Shirzadi MR; Rassi Y; Akhavan AA; Mahmoudi B
    PLoS One; 2016; 11(8):e0161317. PubMed ID: 27574805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency Distribution of Cutaneous Leishmaniasis in the Central Region of Iran.
    Ayatollahi J; Aghaee Z; Tajfiruzeh A; Shahcheraghi SH
    Turkiye Parazitol Derg; 2021 Mar; 45(1):45-48. PubMed ID: 33685068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Cutaneous Leishmaniasis in Turkey: A Retrospective Analysis of 8047 Cases.
    Solmaz A; An İ; Acar U; Aksoy M
    Acta Dermatovenerol Croat; 2024 Mar; 32(1):44-49. PubMed ID: 38946187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of geo-climatic determinants on the distribution of cutaneous leishmaniasis in a recently emerging focus in eastern Iran.
    Karamian M; Ghatee MA; Shayesteh M; Taylor WR; Mohebi-Nejad S; Taheri G; Jamavar MR
    Parasit Vectors; 2021 Oct; 14(1):538. PubMed ID: 34654461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study.
    Uribe-Restrepo AF; Prieto MD; Cossio A; Desai MM; Castro MDM
    Am J Trop Med Hyg; 2019 Feb; 100(2):306-310. PubMed ID: 30628567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
    Mohammadzadeh M; Behnaz F; Golshan Z
    J Infect Public Health; 2013 Apr; 6(2):120-4. PubMed ID: 23537825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.